DRG Epidemiology’s coverage of hereditary angioedema (HAE) comprises epidemiological estimates of key patient populations across the mature (the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan) and emerging pharmaceutical markets (Brazil, China, India, Mexico, Russia, South Korea and Turkey), as well as countries from Americas, Asia Pacific, Europe, Middle East and Africa. We report the prevalence of HAE for each country, as well as annualized case counts projected to the national population.

DRG Epidemiology’s HAE forecast will answer the following questions:

  • Of all people with HAE, how many in each country have been formally diagnosed?
  • How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of HAE over the forecast period?
  • How many people with diagnosed HAE have type I and type II HAE.

All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.

DRG Epidemiology provides at least ten years of forecast data for the following HAE patient populations:

  • Prevalent cases by diagnosis status.
  • Prevalent cases with type I and type II HAE.

Table of contents

  • Hereditary Angioedema - Epidemiology - Asia Pacific Data
    • Introduction
      • Key Findings
        • Overview
          • Prevalence of Hereditary Angioedema per 100,000 Among People of All Ages in 2017 and 2027
          • Patient Flow Diagram for Hereditary Angioedema Across All Countries Under Study in 2018
          • Relative Sizes of the Factors Contributing to the Trend in Prevalent Cases of Hereditary Angioedema over the Next Ten Years
          • Number of Additional Prevalent Cases of Hereditary Angioedema Incurred Over the Period 2017-2027 Across the Countries Under Study
      • Epidemiology Data
      • Methods
        • Diagnosed Prevalence
        • Hereditary Angioedema Subtype
      • Reference Materials
        • Literature Review
          • Studies Included in the Analysis of Hereditary Angioedema
          • Studies Excluded from the Analysis of Hereditary Angioedema
        • Risk/Protective Factors
          • Risk/Protective Factors for Hereditary Angioedema
        • Bibliography

    Author(s): Abey John, MPH

    Abey John is a medical graduate with a Master’s in Public Health and has been associated with DRG since September 2015. He works with a global team of epidemiologists in performing systematic reviews of assigned diseases and prepare forecast models for clients. He also is involved in producing analyses for pharmaceutical drug developers on the descriptive epidemiology of major drug indications in mature and developing markets and have an overall experience of three years working in different healthcare sectors across the country.

    Prior to joining DRG, Abey had been working with Jhpiego (an affiliate of Johns Hopkins Medical University) in implementing Family Planning Health Programs in India with collaborating with the Government of India. He also has worked with a grassroots level NGO as a health team manager which worked for the benefit of the rural population living in the foothills of the Himalayas.